Abstract 11013: Differences in Primary Prevention Recommendations for Statin Therapy Based on National Guidelines Using the Pooled Cohort Equation Risk versus the Coronary Artery Calcium Score: Preliminary Findings From the Vanguard Study for the CorCal Randomized Clinical Outcomes Trial

Joseph B. Muhlestein,Kirk U. Knowlton,Viet T. Le,Donald L. Lappé,Heidi T May,David Min,Kevin M. Johnson,Shanelle Cripps,Lesley Schwab,Shelbi Braun,Tami L. Bair,Jeffrey L. Anderson

Abstract 11013: Differences in Primary Prevention Recommendations for Statin Therapy Based on National Guidelines Using the Pooled Cohort Equation Risk versus the Coronary Artery Calcium Score: Preliminary Findings From the Vanguard Study for the CorCal Randomized Clinical Outcomes Trial

2019

Joseph B. Muhlestein
Kirk U. Knowlton
Viet T. Le
Donald L. Lappé
Heidi T May
David Min
Kevin M. Johnson
Shanelle Cripps
Lesley Schwab
Shelbi Braun
Tami L. Bair
Jeffrey L. Anderson

Background: Primary prevention therapy (PPT) is the best way to treat atherosclerotic cardiovascular disease (ASCVD), and statins are the standard for PPT. However, determining which patients will ...

Keywords:

Coronary artery calcium score
Cardiology
primary prevention
Vanguard
Internal medicine
Clinical trial
Diabetes mellitus
Cohort
Atherosclerotic cardiovascular disease
statin therapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations